Promising cocktail for type 1 diabetes never gets off the ground
Disease control
Terminated
This study aimed to test whether a combination of four drugs (anti-thymocyte globulin, low-dose interleukin-2, adalimumab, and exenatide) could help people newly diagnosed with type 1 diabetes keep making their own insulin. The trial planned to enroll adults aged 18-35 within 120…
Phase: PHASE1, PHASE2 • Sponsor: Camillo Ricordi and Jay Skyler • Aim: Disease control
Last updated May 19, 2026 11:49 UTC